Overview

Treatment of Non-falciparum Malaria

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
Patients with non-falciparum infection will be given artemether-lumefantrine for three days and will be followed up for 28 days. Besides efficacy and safety evaluations a substudy on immunology will be performed.
Phase:
N/A
Details
Lead Sponsor:
Albert Schweitzer Hospital
Treatments:
Artemether
Artemether-lumefantrine combination
Artemether, Lumefantrine Drug Combination
Artemisinins
Lumefantrine